The Duke UNC-Chapel Hill Immunotherapy Training Grant (DUNC-IMTG) is accepting applications for the 2020-2021 admission cycle. DUNC-IMTG is a combined training program from the University of North Carolina at Chapel Hill and Duke University that will focus on training individuals in translational and/or clinical research focusing on tumor immunology and cellular immunotherapy.
Applicants will be selected based on the following criteria:
- Academic qualifications and previous research experience
- Desire to do clinical or translational immune-based transplant/stem cell biomedical research
- Mentor support and funding
The program offers up to two years of support. Applications for 2020-2021 are due at 5 p.m. ET June 15, 2020.